- Home
- DXR vs GROW Comparison
DXR vs GROW Comparison
Compare DXR & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- GROW
- Stock Information
- Founded
- DXR 1970
- GROW 1968
- Country
- DXR United States
- GROW United States
- Employees
- DXR N/A
- GROW N/A
- Industry
- DXR Medical/Dental Instruments
- GROW Investment Managers
- Sector
- DXR Health Care
- GROW Finance
- Exchange
- DXR Nasdaq
- GROW Nasdaq
- Market Cap
- DXR 36.4M
- GROW 31.8M
- IPO Year
- DXR N/A
- GROW N/A
- Fundamental
- Price
- DXR $9.75
- GROW $2.55
- Analyst Decision
- DXR Strong Buy
- GROW
- Analyst Count
- DXR 1
- GROW 0
- Target Price
- DXR $25.00
- GROW N/A
- AVG Volume (30 Days)
- DXR 5.6K
- GROW 29.7K
- Earning Date
- DXR 01-01-0001
- GROW 05-08-2025
- Dividend Yield
- DXR N/A
- GROW 3.52%
- EPS Growth
- DXR 86.16
- GROW N/A
- EPS
- DXR 0.11
- GROW 0.01
- Revenue
- DXR $119,714.00
- GROW $8,932,000.00
- Revenue This Year
- DXR N/A
- GROW N/A
- Revenue Next Year
- DXR N/A
- GROW N/A
- P/E Ratio
- DXR $84.18
- GROW $240.94
- Revenue Growth
- DXR N/A
- GROW N/A
- 52 Week Low
- DXR $6.55
- GROW $2.02
- 52 Week High
- DXR $10.00
- GROW $2.73
- Technical
- Relative Strength Index (RSI)
- DXR 69.88
- GROW 75.16
- Support Level
- DXR $8.68
- GROW $2.42
- Resistance Level
- DXR $9.03
- GROW $2.58
- Average True Range (ATR)
- DXR 0.47
- GROW 0.07
- MACD
- DXR 0.03
- GROW 0.01
- Stochastic Oscillator
- DXR 90.38
- GROW 85.71
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.